论文信息 - The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials - 字舞流文

The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials

A. Levin | K. Mahaffey | M. Jardine | V. Perkovic | D. Wheeler | D. de Zeeuw | D. Charytan | C. Pollock | G. D. Di Tanna | R. Agarwal | Tom Greene | B. Neuen | C. Arnott | Hong Zhang | C. Hockham | G. Bakris | B. Smyth | Amy Kang | Tom H Greene | Hiddo J L Heerspink | H. Heerspink | A. Levin | Hiddo J. L. Heerspink